Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
Sami Hraiech, Jérémy Bourenne, Khaldoun Kuteifan, Julie Helms, Julien Carvelli, Marc Gainnier, Ferhat Meziani, Laurent Papazian
Abstract
International audience
Topics & Concepts
HydroxychloroquineMedicineAzithromycinRitonavirLopinavirLopinavir/ritonavirSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Respiratory distressAcute respiratory distress2019-20 coronavirus outbreakRhinovirusVirologyIntensive care medicineRespiratory systemInternal medicineAnesthesiaViral loadHuman immunodeficiency virus (HIV)LungAntiretroviral therapyInfectious disease (medical specialty)MicrobiologyOutbreakAntibioticsDiseaseBiologyCOVID-19 Clinical Research StudiesInfectious Encephalopathies and EncephalitisPharmacological Receptor Mechanisms and Effects